Abstract Adipose tissue is regarded as an active metabolic and endocrine organ producing adipokines. The purpose of the study was to evaluate adiponectin and leptin concentrations in rheumatoid arthritis (RA) patients (pts) in relation to disease duration and activity. The study group consisted of 80 RA pts. Serum adiponectin and leptin concentrations remained within normal ranges. Adiponectin concentration correlated positively both with the age and disease duration. Both adipokines levels correlated negatively with glomerular Wltration rate. There were signiWcant positive correlations between adipokines' concentrations and lipid proWle components (between adiponectin and HDL-cholesterol, leptin and total cholesterol and LDLcholesterol). In pts with long-standing RA, there was a negative correlation between adiponectin and numbers of tender, swollen joints and a positive relationship between leptin level and DAS28. The results conWrm adipokines' involvement in the process of inXammation and atherosclerosis: protective and antiinXammatory adiponectin eVect and proatherogenic and proinXammatory leptin function.
Introduction
Rheumatoid arthritis (RA) is a chronic, systemic, inXammatory disease, which aVects predominantly synovial joints, causing irreversible joint destruction. Although RA is considered to be a non-fatal disease, higher overall mortality is associated with the disease. Life expectancy in RA patients (pts) is reduced by an average of 3-18 years in comparison with non-RA population [1, 2] . One of the most frequent causes of death is cardiovascular disease (CVD), due to the development of premature, accelerated atherosclerosis [1] [2] [3] . Obesity is an established risk factor for coronary artery disease (CAD) and increased mortality in the general population. However, chronic RA inXammation is accompanied by loss of body cell mass (BCM), deWned as rheumatoid cachexia [1] . White adipose tissue (WAT) is the main energy store of the body, involved in regulation of energy homeostasis and metabolism. WAT is also currently considered a highly active endocrine organ that produces a number of biologically active molecules called adipokines [4] [5] [6] . More than 50 adipokines have been identiWed up till now: chemokines, cytokines [tumor necrosis factor-(TNF-), interleukin-1 (IL-1 ), IL-6, IL-8, IL-10], complement system proteins, proteins involved in hemostasis, glucose homeostasis (adiponectin, resistin), lipid metabolism, angiogenesis and appetite regulation (leptin) [4, 7] .
Adiponectin is a protein, mainly produced by adipocytes and abundantly present in the circulation, accounting for 0.01% of total plasma protein. It is associated with glucose and lipid metabolism. Adiponectin exerts anti-inXammatory action, which results from the reduction of secretion and activity of TNF-and IL-6, as well as induction of IL-10 and IL-1 receptor antagonist (IL-1Ra) [4] . Decreased adiponectin levels in hypertensive pts are correlated with endothelial dysfunction, which represents the earliest stage of atherosclerosis. Higher adiponectin levels are linked with a lower risk of myocardial infarction [8] .
Leptin is a peptide, produced mainly by WAT cells and its circulating levels are directly correlated with WAT mass. The main role of leptin is the regulation of body weight by inhibiting food intake and stimulation of energy expenditure at the hypothalamic level [9] . Leptin levels increase during infection and inXammation, as a result of enhanced production, mediated by pro-inXammatory cytokines (TNF-, IL-1 , IL-6). Leptin induces neutrophil chemotaxis, activates monocytes and macrophages, enhancing their phagocytic activity. It also regulates T-cell proliferation and activity, driving T-cell diVerentiation toward Th 1 response, accounting for pro-inXammatory activity [9, 10] . On the other hand, it has been reported that leptin may also stimulate production of anti-inXammatory cytokines by monocytes and macrophages [11] .
ConXicting data on adipokines' role in RA have been reported. Leptin concentrations were found to be similar [12] [13] [14] [15] [16] , lower [17] , or higher [18, 19] in comparison with healthy controls or with pts with osteoarthritis (OA) [20] . Plasma levels of adiponectin, leptin and visfatin were found to be increased in RA pts [21] or did not diVer signiWcantly in RA pts and in healthy controls [22] .
The aim of the study was to investigate adiponectin and leptin concentrations in a group of RA pts in relation with diVerent disease duration and activity.
Materials and methods
The study group consisted of 80 consecutive RA pts treated in the Department of Rheumatology and Connective Tissue Diseases, Medical University of Lublin. All patients fulWlled the American College of Rheumatology criteria for RA diagnosis [23] . Informed consent was obtained from the patients according to the Declaration of Helsinki. The Ethical Committee of the Medical University of Lublin approved the design of the study.
Patients' charts were reviewed for demographic information, clinical diagnosis, radiographic information.
Erosive form of RA was diagnosed in those pts who presented erosions on joint surfaces of bones in radiograms of hands and/or feet, according to Steinbrocker et al.'s criteria [24] . Extra-articular symptoms observed in the pts included: rheumatoid nodules, amyloidosis, sicca syndrome, interstitial lung disease. Disease activity was determined using the 28 joints Disease Activity Score (DAS28), calculated with the number of swollen and tender joints, patient's global assessment of disease activity and erythrocyte sedimentation rate (ESR).
Routine laboratory data were determined in all patients: C-reactive protein (CRP), ESR, creatinine, hemoglobin (Hb), erythrocyte (ERY) and platelet (PLT) count. ModiWcation of diet in renal diseases (MDRD) was calculated for every patient to estimate the glomerular Wltration rate (GFR) using serum creatinine concentration and demographic factors [25] . Serum level of CRP was measured by immunoturbidimetric assay, with the upper limit of the normal range at 5 mg/l. Total cholesterol (TC), high-density lipoproteins (HDL) cholesterol, triglycerides (TG) were also measured using the standard enzymatic technique (BIOMAXIMA). Low density lipoproteins (LDL) cholesterol was calculated according to the Friedewald formula. Assessment of nutritional status markers [serum albumin, body mass index (BMI), tricipital skin fold (TSF)] was performed. Serum albumin was measured by photometric test with bromocresol green (normal range 3.8-5.1 g/dl). TSF was measured in both upper limbs, in the mid-point between acromion and olecranon with a Harpenden calliper. The mean of these two measures was calculated for every patient. Although long disease duration was noticed in half of our pts, the signs of malnutrition syndrome (BMI <20 kg/m², albumin level <3 g/dl) were observed only in one female patient.
Serum samples were obtained and stored at ¡80°C. Adiponectin was determined by a commercial enzymelinked immunosorbent assay (ELISA) (Human Adiponectin Quantikine, R&D, Germany). The normal range of serum adiponectin according to manufacturer's data was between 0.87 and 21.4 g/ml (mean 6.64); the mean detection limit was 0.246 ng/ml. Leptin was determined by a commercial enzyme-linked immunosorbent assay (ELISA) (Human Leptin Quantikine, R&D, Germany). The normal range of serum leptin according to manufacturer's data was in women between 3.88 and 77.27 ng/ml (mean 20.68); in men between 2.21 and 11.15 ng/ml (mean 4.76); detection limit 7.8 pg/ml.
Statistics
Correlation between quantitative variables was assessed by Spearman's correlation coeYcients. In order to compare subgroups of patients, Student's test or non-parametric Mann-Whitney U test, respectively, were used. For all tests, P values less or equal to 0.05 were considered signiWcant. Table 1 presents the basic characteristics of the study group. The mean number of tender joints was 9.61 (7.2) (range 0-28), the mean number of swollen joints was 7.1 (5.1) (range 0-19). The mean patient's global assessment of disease activity (visual analogue scale 0-100 mm) was 52.9 (24.1) (range 0-93). High disease activity (DAS28 > 5.1) was noted in 50 pts (62.5%) (47 women and 3 men) and moderate or low disease activity (DAS28 · 5.1) in 30 pts (37.5%) (25 women and 5 men). Table 2 presents diVerences between pts with long-standing RA (disease duration >10 years) and with shorter disease duration (·10 years).
Results

Demographic and disease-related variables
All the patients were treated in the past with at least one disease modifying antirheumatic drug (DMARD) which included: methotrexate (MTX), leXunomide (LEF), sulphasalazine (SS), chloroquine (HQ), intramuscular gold salts (GS), cyclosporin A (CYA), cyclophosphamide (CYC). At the time of evaluation 77 pts were treated with DMARDs: MTX (27 pts, 35.1%), LEF (23 pts, 29.9%), SS (5 pts, 6.5%), HQ (3 pts, 3.9%), CYA (2 pts, 2.6%), CYC (2 pts, 2.6%), combination of MTX and LEF (7 pts, 9.1%), MTX and CYA (4 pts, 5.2%), MTX and inXiximab (3 pts, 3.9%), MTX and etanercept (1 pts, 1.3%). In 47 pts (58.8%) lowdose prednisone (5-10 mg/day) was used in the treatment.
Serum adiponectin concentration
The mean (SD) adiponectin serum concentration in all the pts was 15.2 (9.4) g/ml (range 2.95-58.89) and maintained within the normal range. Adiponectin levels did not diVer signiWcantly in women and in men [15.5 (9.6) g/ ml vs. 11.4 (7.9) g/ml]. There were no correlations between adiponectin and BMI as well as TSF.
In pts with long-standing RA, adiponectin levels were signiWcantly higher than in pts with disease duration <10 years [17.7 (11. 3) g/ml (range 2.95-58.9) vs. 12.7 (6.4) g/ml (range 4.0-31.1) (P = 0.047) (Fig. 1)] . Serum adiponectin levels correlated positively both with the age of pts (r S = 0.32, P = 0.003) and the disease duration (r S = 0.38, P = 0.0006) ( Table 3 ). There was a signiWcant negative correlation between adiponectin concentration and MDRD GFR (r S = ¡0.23, P = 0.04) ( Table 3) .
A negative correlation was found between adiponectin level and the number of swollen joints (r S = ¡0.26, P = 0.02). There was also a strong positive correlation between serum adiponectin and HDL-cholesterol (r S = 0.40, P = 0.0003) ( Table 3) .
Serum leptin concentration
The mean (SD) leptin serum concentration was higher in women 11.13 (9.8) ng/ml (range 0.9-47.6) than in men 3.6 (5.6) ng/ml (range 0.5-17.5) and the diVerence was statistically signiWcant (P = 0.001). Mean leptin concentrations in our pts remained within normal ranges according to manufacturer's data. Leptin level was above normal range in one male patient due to high BMI (30.3 kg/m 2 ). Leptin levels below normal range were observed in 23 pts (18 women and 5 men) and were associated with BMI <20 kg/m 2 in 8 pts (7 women and 1 man). Leptin concentrations correlated positively with BMI both in women (r S = 0.58, P = 0.0001) and in men (r S = 0.94, P = 0.002). There was a positive correlation between leptin levels and TSF (r S = 0.59, P = 0.0001) ( Table 3) .
A borderline, negative correlation was observed between leptin concentration and MDRD GFR (r S = ¡0.22, P = 0.05) ( Table 3) .
There were positive correlations between serum leptin levels and TC levels (r S = 0.32, P = 0.004) and between leptin and LDL-cholesterol levels (r S = 0.34, P = 0.003) ( Table 3) .
Adipokines serum concentrations in pts with long long-standing RA When assessing pts with long-standing RA, we found negative correlations between adiponectin levels and markers of disease activity: number of tender joints (r S = ¡0.38, P = 0.02), number of swollen joints (r S = ¡0.45, P = 0.003) and a borderline correlation with DAS28 (r S = ¡0.31, P = 0.05) ( Table 3) . Stepwise multiple regression analysis demonstrated a positive relationship between DAS28 value and leptin level in pts with long-standing RA (R 2 = 0.158, P = 0.01).
Discussion
In the presented group of RA pts, the mean serum concentrations of adiponectin and leptin remained within normal ranges. However, adipokines' levels were changing in the course of the disease. Adiponectin concentration was signiWcantly higher in the group of pts with long-standing RA in comparison with pts with disease duration <10 years. That relationship was noted in spite of comparable inXammatory disease activity in both groups. It was observed that adiponectin concentration signiWcantly increased in relation with the increasing age of pts and disease duration. Additionally, there was a correlation between adiponectin concentration and the value of MDRD GFR, which is a good indicator of renal function, much better than serum creatinine concentration or creatinine clearance [25] . The observation indicates that increasing adiponectin level might be associated with progressive reduction of glomerular Wltration rate in the course of the disease. Our results support the idea that adipokines inXuence the inXammatory process activity in the course of RA. Negative correlations between adiponectin concentrations and symptoms of joint disease activity (number of tender and swollen joints, DAS28 value) contribute to the anti-inXammatory adiponectin function. In contrast, leptin concentration was positively related to DAS28 value, which may be connected with the pro-inXammatory leptin role.
There were also signiWcant correlations between concentrations of adipokines and lipid proWle components. It was observed that the increased adiponectin level was associated with increased HDL-cholesterol, whereas increased leptin level was related to increased TC and LDL-cholesterol levels. The observation suggests a protective metabolic function of adiponectin and proatherogenic leptin role.
Consistent with reports in literature, in our group of pts leptin levels were signiWcantly higher in women than in men and correlated positively with markers of nutritional status (BMI and TSF). TSF is an objective parameter of nutritional status and gives information about fat mass exclusively [26] .
According to the literature, leptin levels are higher in women than in men. Circulating leptin levels are directly correlated with WAT mass and BMI [4, 12, 20] . We did not Wnd a relationship between adiponectin and BMI or TSF, similar to the previous reports [27, 28] . Nakatani et al. [29] reported that in Japanese adults adiponectin levels correlated negatively with BMI, TC, TG and positively with HDL-cholesterol. We found no reports on relationship between adipokines and lipid proWle changes in RA pts.
Increasing number of reports describing diVerential and conXicting results, have been presented in literature on adipokines' role in inXammatory diseases and in RA.
The evidence shows that leptin acts as a pro-inXammatory cytokine. From a structural point of view leptin belongs to the type 1 cytokine superfamily. It may be produced not only by adipocytes, but also by inXammatory cells. DiVerent inXammatory stimuli (TNF-, IL-1, IL-6, lipopolysaccharide) regulate leptin mRNA expression and circulating levels, suggesting that short-time release of stored leptin is associated with acute inXammation. Leptin induces T-cell activation and modiWes T-cell diVerentiation towards Th 1 response, connected with pro-inXammatory function [30] . In chronic inXammation, prolonged stimulation induces a suppression of leptin synthesis [12, 30] .
In RA pts leptin concentrations were found to be similar to those of healthy controls [13] [14] [15] [16] and pts with osteoarthritis (OA) [20] . No correlation was reported between serum leptin levels and disease stages or disease activity, deWned with the value of ESR, CRP [14, 16] , DAS [13, 20] or presence of joint erosions [16] . In contrast, Popa et al. [15] reported that in RA pts plasma leptin concentration was inversely correlated with markers of inXammation (IL-6, CRP), suggesting, that long-term stimulation of WAT by pro-inXammatory cytokines inhibits leptin production. Lee et al. [31] reported signiWcantly higher serum leptin levels in RA pts with high disease activity, as well as positive correlations between leptin and DAS28, CRP values. In other publications, leptin levels were reported to be signiWcantly higher in RA pts than in control subjects [18, 19, 21, 32] , signiWcantly correlated with CRP [21] or had no correlation with clinical and laboratory parameters of disease activity [32] . Bokarewa et al. found that leptin plasma concentrations were higher than in synovial Xuid samples obtained simultaneously. Decreased leptin level in synovial Xuid was associated with non-erosive joint disease, suggesting a protective leptin eVect against RA destruction [18] .
Earlier, when assessing the group of 37 RA pts, we found that leptin concentrations were signiWcantly higher in pts with erosive joint disease than in pts without erosions. In pts with long-standing RA, leptin levels correlated positively with value of DAS28, ESR and number of tender joints. There was also a tendency of correlation between leptin level and cystatin C concentration (novel renal function parameter). The results suggested that leptin levels were increased in pts with higher disease activity and the risk of progressive joint destruction [12] . In the present study, we conWrmed the observation of pro-inXammatory leptin function in the course of RA. Additional observation on the metabolic role of leptin were also performed.
Many reports have been published in the Weld of endocrinology and CVD, dealing with the protective metabolic Adiponectin itself reduces the release of pro-inXammatory cytokines and increases production of ant-inXammatory ones from activated inXammatory cells. Pro-inXammatory cytokines (TNF-, IL-6) suppress adiponectin production and thus an inverse correlation has been noted between adiponectin concentration and markers of inXammation (CRP, IL-6) [33] . Chronic inXammation associated with obesity, diabetes, atherosclerosis and CVD is characterized by decreased adiponectin level [33] . Recently, there has been a growing interest in adiponectin role in pts with CHF. High plasma levels of adiponectin observed in pts with established CHF were associated with poor prognosis and mortality. Reduced renal clearance could account for higher adiponectin concentration in CHF pts [34] . In haemodialysis pts low plasma adiponectin levels were associated with pre-existing CVD and predicted mortality outcomes [35] .
Some reports suggest that in joint diseases adiponectin might exert pro-inXammatory eVects. Adiponectin can induce the cultured synovial Wbroblasts to release mediators of joint destruction: IL-6 and metalloproteinase-1 (MMP-1), but not TNF-and IL-1 [36] . High concentrations of adiponectin were observed in synovial Xuid of RA pts with synovial Wbroblasts distinctly rich in adiponectin [37] . In contrast, Lee et al. observed that adiponectin signiWcantly mitigated the severity of arthritis in collagen-induced arthritis in mice, with decreased expression of TNF-, IL-1 , MMP-3 in RA synovial Wbroblasts. These data suggest an anti-inXammatory adiponectin role in the pathophysiology of RA [38] .
In clinical observations, it was reported that adiponectin plasma levels of RA pts did not diVer signiWcantly [21] or were markedly increased in comparison with healthy controls [21, 27] . No correlation was found between adiponectin and systemic inXammatory markers (CRP, ESR) [27] or a positive correlation with CRP was noted [21] . Increased adiponectin concentrations were observed in synovial Xuid of RA in comparison with OA pts, which suggests a proinXammatory role in arthritis [27, 39] . Serum adiponectin levels were higher than those in synovial Xuid, indicating that peripheral fat stores are major producers of serum adiponectin [27] .
Recent reports in literature demonstrate that anti-TNF treatment was associated with an increase [8, 22, 28, 39] or no change in adiponectin levels [40] . The adiponectin levels were positively correlated with the endothelium-dependent vasodilatation and negatively with DAS28 [8] . Other reports demonstrated no correlation between adiponectin and clinical backgrounds or markers of disease activity after anti-TNF treatment [28, 41] .
Conclusions
Although adiponectin and leptin concentrations remained within normal ranges in RA pts, a signiWcant increase of adiponectin level was observed in relation to the age and disease duration. That might be connected with decreased GFR in older pts. SigniWcant correlations between adipokines' concentrations and lipid proWle components conWrm their involvement in the process of atherosclerosis: protective adiponectin eVect and proatherogenic leptin function. In pts with long-standing RA, adipokines' concentrations were signiWcantly associated with the joints disease activity, indicating anti-inXammatory adiponectin and proinXammatory leptin role.
